Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patients with mRCC treated with tyrosine kinase inhibit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Florian Janisch, Christina Kienapfel, Constantin Fühner, Thomas Klotzbücher, Phillip Marks, Tobias Hillemacher, Christian P. Meyer, Takehiro Iwata, Mehdi Kardoust Parizi, Guido Sauter, Margit Fisch, Shahrokh F. Shariat, Roland Dahlem, Michael Rink
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
renal cell carcinoma
tyrosine kinase inhibitors
targeted therapy
sarcomatoid histology
therapy regime
Surgery
RD1-811
Acceso en línea:https://doaj.org/article/46f83ba3e8464463b86b544dabfebe2d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/46f83ba3e8464463b86b544dabfebe2d

Ejemplares similares